(1) Background: We describe our experience with cystic fibrosis (CF) patients treated with
bronchial artery embolization (BAE) for sub-massive hemoptysis to understand if early …

Background and Objectives: Roughly 10% of cancer patients experience an episode of
bleeding. The bleeding severity can range from occasional trivial bleeds to major bleeding …

Background and Objectives: Transcatheter arterial embolization (TAE) is part of the daily
practice of most interventional radiologists worldwide. The ideal liquid embolic agent is far …

Background and Objectives: Transcatheter arterial embolization (TAE) is the mainstay of
treatment for acute major hemorrhage, even in patients with coagulopathy and spontaneous …

Embolization in pediatric patients encompasses a large spectrum of indications, ranging
from the elective treatment of congenital diseases of the cardiovascular system to the urgent …

Objectives To identify the prevalence of non-bronchial systemic culprit arteries and their
relationship to bleeding lobes in patients with hemoptysis with bronchiectasis and chronic …

Objective The aim of this study was to evaluate the efficacy and safety of endovascular
treatment of hemoptysis caused by primary lung cancer. Methods We conducted a single …

Background Nearly half of bronchiectasis patients receiving bronchial artery embolization
(BAE) still have recurrent hemoptysis, which may be life-threatening. Worse still, the …

Background To retrospectively evaluate the effectiveness of bronchial artery embolization
(BAE) compared with conservative therapy for the treatment of frequent hemoptysis caused …

Background Bronchiectasis has high rates of hemoptysis and recurrent hemoptysis, which is
inconsistent among various etiologies. Idiopathic bronchiectasis and post-tuberculous …